Cardiovascular clinical applications of PET/MRI

Clinical and Translational Imaging

Volumn 1, Issue 1, 2013, Pages 65-71

  Ratib, Osman ^a   Nkoulou, René ^a   Schwaiger, Markus ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hybrid imaging; Molecular imaging; Nuclear medicine; PET MRI

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; SODIUM FLUORIDE F 18; TRACER;

ATHEROSCLEROTIC PLAQUE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; HEART INFARCTION; HEART PERFUSION; HUMAN; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; META ANALYSIS (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

EID: 84879976155     PISSN: 22815872     EISSN: 22817565     Source Type: Journal    
DOI: 10.1007/s40336-013-0008-0     Document Type: Review

References (36)

1. Flotats A, Knuuti J, Gutberlet M et al (2011) Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging 38(1): 201-212.
2. Schwitter J, Wacker CM, van Rossum AC et al (2008) MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 29(4): 480-489.
3. Kim RJ, Wu E, Rafael A et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343(20): 1445-1453.
4. Balyasnikova S, Lofgren J, de Nijs R, Zamogilnaya Y, Hojgaard L, Fischer BM (2012) PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging. Am J Nucl Med Mol Imaging 2(4): 458-474.
5. Zaidi H, Ojha N, Morich M et al (2011) Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol 56(10): 3091-3106.
6. Delso G, Furst S, Jakoby B et al (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52(12): 1914-1922.
7. Stegger L, Martirosian P, Schwenzer N et al (2012) Simultaneous PET/MR imaging of the brain: feasibility of cerebral blood flow measurements with FAIR-TrueFISP arterial spin labeling MRI. Acta Radiol 53(9): 1066-1072.
8. De Bruyne B, Pijls NH, Kalesan B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367(11): 991-1001.
9. Stone GW (2012) In search of vulnerable plaque. Circ Cardiovasc Imaging 5(4): 428-430.
10. van Werkhoven JM, Bax JJ, Nucifora G et al (2009) The value of multi-slice-computed tomography coronary angiography for risk stratification. J Nucl Cardiol 16(6): 970-980.
11. Budoff MJ, Dowe D, Jollis JG et al (2008) Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol 52(21): 1724-1732.
12. Jahnke C, Paetsch I, Nehrke K et al (2005) Rapid and complete coronary arterial tree visualization with magnetic resonance imaging: feasibility and diagnostic performance. Eur Heart J 26(21): 2313-2319.
13. Nagata M, Kato S, Kitagawa K et al (2011) Diagnostic accuracy of 1. 5-T unenhanced whole-heart coronary MR angiography performed with 32-channel cardiac coils: initial single-center experience. Radiology 259(2): 384-392.
14. Di Carli MF, Murthy VL (2011) Cardiac PET/CT for the evaluation of known or suspected coronary artery disease. Radiographics 31(5): 1239-1254.
15. Schwitter J, DeMarco T, Kneifel S et al (2000) Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. Circulation 101(23): 2696-2702.
16. Ibrahim T, Nekolla SG, Schreiber K et al (2002) Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol 39(5): 864-870.
17. 15O] water techniques. Circulation 93(11): 2000-2006.
18. 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 54(2): 150-156.
19. 13N-ammonia and validation with microspheres in a pig model. Circulation 119(17): 2333-2342.
20. Rees G, Bristow JD, Kremkau EL et al (1971) Influence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med 284(20): 1116-1120.
21. Horn HR, LE Teichholz, Cohn PF, Herman MV, Gorlin R (1974) Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine. The epinephrine ventriculogram. Circulation 49(6): 1063-1071.
22. Diamond GA, Forrester JS, de Luz PL, Wyatt HL, Swan HJ (1978) Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 95(2): 204-209.
23. Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31(20): 2501-2555.
24. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39(7): 1151-1158.
25. Kaandorp TA, Lamb HJ, van der Wall EE, de Roos A, Bax JJ (2005) Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction. Heart 91(10): 1359-1365.
26. Beanlands RS, Nichol G, Huszti E et al (2007) F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 50(20): 2002-2012.
27. Bonow RO, Maurer G, Lee KL et al (2011) Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 364(17): 1617-1625.
28. Depre C, Vanoverschelde JL, Gerber B, Borgers M, Melin JA, Dion R (1997) Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 113(2): 371-378.
29. Underwood SR, Bax JJ, vom Dahl J et al (2004) Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J 25(10): 815-836.
30. Ambrose JA, Tannenbaum MA, Alexopoulos D et al (1988) Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 12(1): 56-62.
31. Stone GW, Maehara A, Lansky AJ et al (2011) A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364(3): 226-235.
32. Virmani R, Burke AP, Farb A, Kolodgie FD (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47(8 Suppl): C13-C18.
33. 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging 2(4): 331-338.
34. Gaertner FC, Kessler H, Wester HJ, Schwaiger M, Beer AJ (2012) Radiolabelled RGD peptides for imaging and therapy. Eur J Nucl Med Mol Imaging 39(Suppl 1): S126-S138.
35. 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol 59(17): 1539-1548.
36. 18F] fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. J Nucl Cardiol. 19(6): 1211-1225.